Oscar Health, Inc. (OSCR)

NYSE: OSCR · Real-Time Price · USD

27.67

-0.23 (-0.82%)

At close: Aug 10, 2026, 4:00 PM EDT

27.72

+0.05 (0.18%)

After-hours: Aug 10, 2026, 7:58 PM EDT

Oscar Health Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	15,319	11,701	9,178	5,863	3,964	1,839
Revenue Growth	42.82%	27.50%	56.54%	47.92%	115.57%	297.30%
Gross Profit	3,088	1,682	1,845	1,221	682.84	-140.32
Operating Income	629.72	-396.36	57.27	-235.62	-589.87	-544.48
Net Income	550.74	-443.15	25.43	-270.73	-606.28	-572.61
Earnings Per Share	1.40	-1.69	0.10	-1.22	-2.85	-3.20
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Premium	15,041	11,470	8,971	5,686	3,871	1,831
Investment Income	248.23	202.94	185.73	155.45	27.59	-
Services and Other	29.58	28.59	20.58	21.35	64.93	-
Revenue (Total)	15,319	11,701	9,178	5,863	3,964	1,839

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	8,556	3,991	2,152	2,560	2,956	1,691
Total Debt	431.63	430.1	299.56	298.78	298	0
Net Cash (Debt)	8,124	3,561	1,852	2,261	2,658	1,691
Net Cash Growth	150.96%	92.24%	-18.10%	-14.92%	57.17%	61.02%
Net Cash Per Share	26.95	13.57	6.97	10.20	12.51	9.45

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	4,419	1,095	978.19	-272.16	380.35	-181.75
Capital Expenditures	-38.63	-36.37	-27.9	-25.58	-29.01	-25.89
Free Cash Flow	4,380	1,058	950.3	-297.74	351.34	-207.63
Free Cash Flow Growth	264.51%	11.38%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	20.16%	14.38%	20.10%	20.82%	17.23%	-7.63%
Operating Margin	4.11%	-3.39%	0.62%	-4.02%	-14.88%	-29.61%
Pretax Margin	3.85%	-3.74%	0.36%	-4.56%	-15.39%	-31.03%
Profit Margin	3.60%	-3.79%	0.28%	-4.62%	-15.38%	-31.08%
FCF Margin	28.59%	9.05%	10.35%	-5.08%	8.86%	-11.29%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	14.50	-	134.40	-	-	-
Forward PE	17.00	278.94	28.43	-	-	-
P/FCF Ratio	1.95	4.04	3.54	-	1.51	-
PS Ratio	0.56	0.37	0.37	0.36	0.13	0.90